| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Neoplasms | 13 | 2021 | 123 | 3.590 |
Why?
|
| CRISPR-Cas Systems | 10 | 2024 | 317 | 2.120 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 8 | 2021 | 93 | 1.970 |
Why?
|
| Gene Editing | 8 | 2024 | 234 | 1.940 |
Why?
|
| Teratoma | 4 | 2021 | 124 | 1.440 |
Why?
|
| Embryonic Germ Cells | 3 | 2021 | 7 | 1.220 |
Why?
|
| Embryo, Mammalian | 5 | 2024 | 450 | 1.210 |
Why?
|
| Cell Differentiation | 7 | 2025 | 1950 | 1.160 |
Why?
|
| Mice | 52 | 2025 | 18366 | 1.060 |
Why?
|
| Mice, Knockout | 21 | 2025 | 3863 | 1.010 |
Why?
|
| Time-Lapse Imaging | 1 | 2024 | 6 | 0.860 |
Why?
|
| Embryonal Carcinoma Stem Cells | 3 | 2021 | 6 | 0.800 |
Why?
|
| Embryonic Development | 2 | 2024 | 224 | 0.780 |
Why?
|
| Animals | 54 | 2025 | 34215 | 0.740 |
Why?
|
| Sex Differentiation | 1 | 2021 | 18 | 0.690 |
Why?
|
| Machine Learning | 1 | 2024 | 375 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 4737 | 0.620 |
Why?
|
| Germ Cells | 4 | 2023 | 204 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2024 | 3419 | 0.570 |
Why?
|
| Cyclin D1 | 2 | 2016 | 109 | 0.560 |
Why?
|
| Osteoblasts | 3 | 2025 | 158 | 0.560 |
Why?
|
| Intestinal Polyposis | 2 | 2015 | 17 | 0.550 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 73 | 0.550 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 160 | 0.520 |
Why?
|
| Testis | 2 | 2017 | 413 | 0.500 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 16 | 0.480 |
Why?
|
| Genes, Lethal | 2 | 2022 | 76 | 0.480 |
Why?
|
| Interleukins | 1 | 2015 | 121 | 0.430 |
Why?
|
| Ovary | 1 | 2017 | 360 | 0.420 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 834 | 0.410 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 455 | 0.380 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 265 | 0.370 |
Why?
|
| Mice, Transgenic | 9 | 2024 | 2366 | 0.360 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 79 | 0.350 |
Why?
|
| Genome | 4 | 2023 | 473 | 0.340 |
Why?
|
| Disease Models, Animal | 10 | 2025 | 4682 | 0.330 |
Why?
|
| Transgenes | 3 | 2025 | 324 | 0.330 |
Why?
|
| Mutation | 12 | 2024 | 6196 | 0.320 |
Why?
|
| Alleles | 7 | 2024 | 1708 | 0.320 |
Why?
|
| Cell Proliferation | 5 | 2022 | 2478 | 0.320 |
Why?
|
| Osteoporosis | 2 | 2021 | 134 | 0.310 |
Why?
|
| Phenotype | 11 | 2025 | 4528 | 0.310 |
Why?
|
| Neoplasm Proteins | 4 | 2024 | 677 | 0.290 |
Why?
|
| Integrases | 3 | 2023 | 158 | 0.290 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 54 | 0.290 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 639 | 0.290 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 11 | 0.290 |
Why?
|
| Intellectual Disability | 3 | 2021 | 1082 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 2013 | 0.280 |
Why?
|
| Mice, 129 Strain | 3 | 2018 | 97 | 0.280 |
Why?
|
| Gene Deletion | 5 | 2021 | 772 | 0.280 |
Why?
|
| Stem Cells | 4 | 2024 | 713 | 0.270 |
Why?
|
| Male | 25 | 2025 | 65321 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2024 | 635 | 0.270 |
Why?
|
| Forkhead Transcription Factors | 2 | 2021 | 372 | 0.250 |
Why?
|
| Genes, Essential | 2 | 2024 | 43 | 0.250 |
Why?
|
| Chromosomes, Artificial | 1 | 2006 | 1 | 0.250 |
Why?
|
| Genetic Vectors | 3 | 2025 | 907 | 0.250 |
Why?
|
| Dependovirus | 2 | 2025 | 162 | 0.240 |
Why?
|
| Female | 23 | 2025 | 71262 | 0.230 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 551 | 0.230 |
Why?
|
| Oocytes | 2 | 2024 | 283 | 0.220 |
Why?
|
| Membrane Proteins | 3 | 2024 | 1612 | 0.220 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 14 | 0.220 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2025 | 8 | 0.220 |
Why?
|
| RANK Ligand | 1 | 2025 | 51 | 0.220 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2004 | 34 | 0.220 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 16 | 0.210 |
Why?
|
| Osteoclasts | 2 | 2025 | 73 | 0.210 |
Why?
|
| Epithelial Cells | 2 | 2022 | 900 | 0.210 |
Why?
|
| Viral Tropism | 1 | 2025 | 48 | 0.210 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2004 | 90 | 0.210 |
Why?
|
| Zygote | 1 | 2024 | 29 | 0.210 |
Why?
|
| Macular Degeneration | 1 | 2025 | 91 | 0.210 |
Why?
|
| Mice, Inbred Strains | 3 | 2023 | 275 | 0.200 |
Why?
|
| Eye Proteins | 1 | 2025 | 239 | 0.200 |
Why?
|
| Gene Targeting | 1 | 2004 | 171 | 0.200 |
Why?
|
| SOX9 Transcription Factor | 1 | 2024 | 91 | 0.200 |
Why?
|
| DNA Helicases | 1 | 2025 | 235 | 0.200 |
Why?
|
| Capsid | 1 | 2023 | 96 | 0.200 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 172 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2025 | 1005 | 0.200 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 2 | 2023 | 113 | 0.190 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 533 | 0.190 |
Why?
|
| Flow Cytometry | 2 | 2018 | 772 | 0.190 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 332 | 0.190 |
Why?
|
| Ciliopathies | 1 | 2022 | 13 | 0.190 |
Why?
|
| Anophthalmos | 1 | 2023 | 24 | 0.190 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2023 | 73 | 0.190 |
Why?
|
| Exons | 3 | 2023 | 769 | 0.190 |
Why?
|
| Coloboma | 1 | 2023 | 41 | 0.190 |
Why?
|
| Signal Transduction | 3 | 2021 | 4693 | 0.190 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2021 | 84 | 0.190 |
Why?
|
| Microphthalmos | 1 | 2023 | 55 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 305 | 0.190 |
Why?
|
| Genotype | 5 | 2021 | 2652 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 151 | 0.190 |
Why?
|
| Eye Abnormalities | 1 | 2023 | 107 | 0.180 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 19 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 288 | 0.180 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2024 | 174 | 0.180 |
Why?
|
| Bone and Bones | 2 | 2021 | 300 | 0.180 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1610 | 0.180 |
Why?
|
| Retina | 1 | 2025 | 462 | 0.180 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 13 | 0.180 |
Why?
|
| Pyroptosis | 1 | 2022 | 36 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2025 | 1131 | 0.170 |
Why?
|
| Coatomer Protein | 1 | 2021 | 29 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 324 | 0.170 |
Why?
|
| Semaphorins | 1 | 2021 | 35 | 0.170 |
Why?
|
| Aniridia | 1 | 2021 | 11 | 0.170 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 34 | 0.170 |
Why?
|
| Spermatogonia | 1 | 2021 | 27 | 0.170 |
Why?
|
| Nuclear Proteins | 2 | 2025 | 1228 | 0.170 |
Why?
|
| Synapses | 1 | 2024 | 446 | 0.170 |
Why?
|
| Endometriosis | 1 | 2024 | 186 | 0.170 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 74 | 0.160 |
Why?
|
| Cornea | 1 | 2025 | 566 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2023 | 2442 | 0.160 |
Why?
|
| Genomics | 2 | 2020 | 1630 | 0.160 |
Why?
|
| Introns | 1 | 2021 | 288 | 0.160 |
Why?
|
| Lung | 3 | 2024 | 1571 | 0.150 |
Why?
|
| Gene Expression | 3 | 2017 | 1503 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 341 | 0.150 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 12 | 0.150 |
Why?
|
| Gene Dosage | 3 | 2017 | 439 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 60 | 0.150 |
Why?
|
| Humans | 28 | 2025 | 131852 | 0.140 |
Why?
|
| Disease | 1 | 2020 | 125 | 0.140 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 74 | 0.140 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 70 | 0.140 |
Why?
|
| Sex Determination Processes | 1 | 2018 | 11 | 0.140 |
Why?
|
| Bone Density | 1 | 2020 | 362 | 0.140 |
Why?
|
| Pregnancy | 3 | 2024 | 7576 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2023 | 984 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 328 | 0.130 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 83 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2357 | 0.130 |
Why?
|
| Sequence Deletion | 2 | 2017 | 519 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 275 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 876 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 108 | 0.120 |
Why?
|
| Complement C5a | 1 | 2016 | 18 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2019 | 450 | 0.120 |
Why?
|
| Aging | 1 | 2024 | 1269 | 0.120 |
Why?
|
| Proteins | 3 | 2023 | 1014 | 0.120 |
Why?
|
| Transcriptome | 3 | 2022 | 1141 | 0.120 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 36 | 0.120 |
Why?
|
| Leydig Cells | 1 | 2016 | 21 | 0.120 |
Why?
|
| Wound Healing | 2 | 2022 | 477 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 771 | 0.120 |
Why?
|
| Sertoli Cells | 1 | 2016 | 76 | 0.120 |
Why?
|
| Meiosis | 1 | 2016 | 112 | 0.120 |
Why?
|
| DNA Damage | 1 | 2019 | 527 | 0.120 |
Why?
|
| Mutagenesis | 3 | 2023 | 335 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 274 | 0.110 |
Why?
|
| Interleukin-33 | 1 | 2015 | 21 | 0.110 |
Why?
|
| Mitosis | 1 | 2016 | 190 | 0.110 |
Why?
|
| Gene Knockout Techniques | 3 | 2022 | 136 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2015 | 62 | 0.110 |
Why?
|
| Mast Cells | 1 | 2015 | 65 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 264 | 0.110 |
Why?
|
| Osteogenesis | 2 | 2024 | 167 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2015 | 184 | 0.110 |
Why?
|
| Base Sequence | 4 | 2022 | 2783 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 231 | 0.110 |
Why?
|
| Homozygote | 2 | 2022 | 548 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 423 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 234 | 0.100 |
Why?
|
| Colonic Polyps | 1 | 2015 | 86 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1304 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 2863 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2012 | 31 | 0.100 |
Why?
|
| Capsid Proteins | 2 | 2023 | 150 | 0.090 |
Why?
|
| Histological Techniques | 1 | 2012 | 19 | 0.090 |
Why?
|
| Nanog Homeobox Protein | 1 | 2012 | 28 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2012 | 79 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1008 | 0.090 |
Why?
|
| Inheritance Patterns | 2 | 2012 | 130 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2019 | 1565 | 0.090 |
Why?
|
| RNA, Messenger | 5 | 2013 | 2573 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 497 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 974 | 0.080 |
Why?
|
| Obesity | 2 | 2016 | 2392 | 0.080 |
Why?
|
| Cytokines | 1 | 2016 | 1354 | 0.080 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 9 | 0.080 |
Why?
|
| Genetic Therapy | 2 | 2025 | 726 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 569 | 0.070 |
Why?
|
| Solubility | 1 | 2008 | 117 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1860 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 1964 | 0.070 |
Why?
|
| Animals, Congenic | 1 | 2008 | 7 | 0.070 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 124 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 154 | 0.070 |
Why?
|
| Zebrafish | 2 | 2021 | 428 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2010 | 377 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2008 | 421 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 611 | 0.060 |
Why?
|
| Epistasis, Genetic | 1 | 2007 | 98 | 0.060 |
Why?
|
| Biometry | 1 | 2008 | 102 | 0.060 |
Why?
|
| Triglycerides | 1 | 2010 | 605 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2948 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 80 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 39 | 0.060 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 36 | 0.060 |
Why?
|
| Genetic Linkage | 1 | 2008 | 471 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 307 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2021 | 858 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 230 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 152 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3535 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 2867 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2007 | 276 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 331 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 10 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 11 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2010 | 683 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2992 | 0.050 |
Why?
|
| Bone Development | 1 | 2025 | 55 | 0.050 |
Why?
|
| Serogroup | 1 | 2025 | 67 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2025 | 366 | 0.050 |
Why?
|
| Osteocalcin | 1 | 2004 | 45 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 279 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 138 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 122 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2024 | 163 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2021 | 15065 | 0.050 |
Why?
|
| X Chromosome | 1 | 2004 | 331 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2024 | 279 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 172 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 1219 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 63 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2004 | 339 | 0.050 |
Why?
|
| Colorimetry | 1 | 2022 | 17 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 25 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2023 | 184 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2022 | 44 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2022 | 74 | 0.050 |
Why?
|
| Cilia | 1 | 2022 | 81 | 0.050 |
Why?
|
| Point-of-Care Testing | 1 | 2022 | 30 | 0.040 |
Why?
|
| Smartphone | 1 | 2022 | 46 | 0.040 |
Why?
|
| Progesterone | 1 | 2024 | 446 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 258 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2023 | 155 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2022 | 86 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2022 | 74 | 0.040 |
Why?
|
| Estrogens | 1 | 2024 | 436 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 71 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 286 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 2697 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 92 | 0.040 |
Why?
|
| Bivalvia | 1 | 2001 | 7 | 0.040 |
Why?
|
| Eye | 1 | 2023 | 227 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 114 | 0.040 |
Why?
|
| Binding Sites | 2 | 2017 | 1148 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 34 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2022 | 312 | 0.040 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 26 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2020 | 54 | 0.040 |
Why?
|
| Endometrium | 1 | 2024 | 291 | 0.040 |
Why?
|
| Facies | 1 | 2021 | 157 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 145 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 111 | 0.040 |
Why?
|
| Brain | 2 | 2024 | 3247 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 172 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 209 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 680 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 97 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 162 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 381 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 202 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2022 | 586 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 220 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 101 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 512 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 265 | 0.040 |
Why?
|
| Methotrexate | 1 | 2022 | 344 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2022 | 458 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 664 | 0.040 |
Why?
|
| Genes | 1 | 2020 | 308 | 0.040 |
Why?
|
| Cell Line | 1 | 2004 | 2592 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 805 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2022 | 832 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 811 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 803 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 360 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 73 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 195 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 338 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 128 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 705 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2022 | 1572 | 0.030 |
Why?
|
| Cell Movement | 1 | 2022 | 885 | 0.030 |
Why?
|
| Internet | 1 | 2021 | 423 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 1224 | 0.030 |
Why?
|
| Amino Acids | 1 | 2020 | 572 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 2148 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 2016 | 36 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 738 | 0.030 |
Why?
|
| Complement Activation | 1 | 2016 | 47 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 244 | 0.030 |
Why?
|
| DNA Primers | 2 | 2007 | 609 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 205 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1489 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 379 | 0.030 |
Why?
|
| Neurons | 1 | 2024 | 1996 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3450 | 0.030 |
Why?
|
| Child | 3 | 2021 | 26331 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1841 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1840 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 1714 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 1673 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 3094 | 0.020 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2012 | 11 | 0.020 |
Why?
|
| Lewis X Antigen | 1 | 2011 | 11 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 891 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2011 | 40 | 0.020 |
Why?
|
| Epigenomics | 1 | 2012 | 186 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 570 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 728 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 748 | 0.020 |
Why?
|
| RNA Splicing Factors | 1 | 2010 | 52 | 0.020 |
Why?
|
| Lipolysis | 1 | 2010 | 76 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2010 | 86 | 0.020 |
Why?
|
| Muscles | 1 | 2010 | 220 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 21003 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 333 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 95 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3928 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 240 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 313 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1352 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 710 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8604 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2007 | 37 | 0.020 |
Why?
|
| Neoplasms | 1 | 2022 | 2964 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1027 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 272 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 692 | 0.010 |
Why?
|
| Glucose | 1 | 2010 | 850 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 10104 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 990 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 1801 | 0.010 |
Why?
|
| Hemocytes | 1 | 2001 | 4 | 0.010 |
Why?
|
| Tumor Protein p73 | 1 | 2001 | 26 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2001 | 38 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 622 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 712 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 489 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31716 | 0.010 |
Why?
|
| Leukemia | 1 | 2001 | 375 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 657 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 2422 | 0.010 |
Why?
|